Integrin-Mediated Adhesion and Chemoresistance of Acute Lymphoblastic Leukemia Cells Residing in the Bone Marrow or the Central Nervous System
Acute Lymphoblastic Leukemia (ALL) is the most common cancer in childhood. Despite a significantly improved prognosis over the last decade with a 5-years survival rate of ~90%, treatment-related morbidity remains substantial and relapse occurs in 10–15% of patients (1). The most common site of relap...
Main Authors: | Bibi Fatima Syed Shah Scharff, Signe Modvig, Hanne Vibeke Marquart, Claus Christensen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.00775/full |
Similar Items
-
Central Nervous System Relapse in Acute Lymphoblastic Leukemia (Study on 160 cases)
by: T Azarm, et al.
Published: (2005-06-01) -
The Role of the Central Nervous System Microenvironment in Pediatric Acute Lymphoblastic Leukemia
by: Peter M. Gordon, et al.
Published: (2017-04-01) -
Precursor T-cell acute lymphoblastic leukemia presenting with bone marrow necrosis: a case report
by: Khoshnaw Najmaddin SH, et al.
Published: (2012-10-01) -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
by: Maria Ilaria Del Principe, et al.
Published: (2014-11-01) -
A cross-talk between integrin β4 and epidermal growth factor receptor induces gefitinib chemoresistance to gastric cancer
by: Jia Huafeng, et al.
Published: (2018-04-01)